首页> 美国卫生研究院文献>World Journal of Gastroenterology >Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis
【2h】

Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis

机译:柳氮磺吡啶对活动性溃疡性结肠炎患者活检黏膜病理及组织学分级的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate the mechanisms of sulfasalazine (SASP) in the treatment of ulcerative colitis (UC).METHODS: Changes of pathological signs and histological grading of 106 patients with active UC were observed before and after the treatment with SASP, 1 g, thrice daily for 6 wk.RESULTS: The effect of SASP on the vasculitis in lamina propria was 48.2% and 17.4% in the mild active UC (P < 0.001) and 68% and 26.7% in the moderate active UC (P < 0.001) before and after treatment. Fibroid necrosis of vessel wall was found in one case of mild UC and two cases of moderate UC before treatment and was not found after treatment. No thrombosis was found in mild UC before and after treatment, while thrombosis was found in one case of moderate UC before treatment. The effect on mucosal glandular abnormality was 30.4% and 13.0% in mild UC (P < 0.05), and 42% and 40% in moderate UC (P > 0.05) before and after treatment. The rate of eosinophil infiltration was 98.2% and 80.4% in mild UC (P < 0.01), and 100% and 91.1% in moderate UC (P < 0.05) before and after treatment. The effect on crypt abscess was 21.4% and 4.4% in mild UC (P < 0.05), and 48% and 13.3% in moderate UC (P < 0.001) before and after treatment. The effect on mucosal pathohistological grading was 2.00 ± 0.84 and 0.91 ± 0.46 in mild UC (P < 0.001), and 2.49 ± 0.84 and 1.31 ± 0.75 in moderate UC (P < 0.001) before and after treatment.CONCLUSION: SASP can improve small vessel lesions and crypt abscesses and reduce neutrophilic and eosinophilic leukocyte infiltration in inflammatory mucosa of UC.
机译:目的:探讨柳氮磺胺吡啶(SASP)治疗溃疡性结肠炎(UC)的机制。方法:观察106例SUC治疗前后1 g,三次三次的106例活动性UC患者的病理征象和组织学分级的变化。结果:SASP对轻度活动性UC的固有层血管炎的影响分别为48.2%和17.4%(P <0.001),中度活动性UC的68%和26.7%(P <0.001)和治疗后。 1例轻度UC和2例中度UC发现血管壁肌瘤坏死,治疗后未见。轻度UC治疗前后均未发现血栓形成,而一例中度UC治疗前未发现血栓形成。治疗前后轻度UC对粘膜腺异常的影响分别为30.4%和13.0%(P <0.05),中度UC对42%和40%(P> 0.05)。治疗前后,轻度UC患者的嗜酸性粒细胞浸润率为98.2%和80.4%,中度UC患者的嗜酸性粒细胞浸润率为100%和91.1%(P <0.05)。治疗前后,轻度UC对隐窝脓肿的影响分别为21.4%和4.4%(P <0.05),中度UC对隐窝脓肿的影响为48%和13.3%(P <0.001)。治疗前后轻度UC对粘膜病理组织学分级的影响分别为2.00±0.84和0.91±0.46(P <0.001),中度UC(P <0.001)为2.49±0.84和1.31±0.75。结论:SASP可以改善小血管病变和隐窝脓肿,并减少UC炎症性粘膜中的嗜中性白细胞和嗜酸性白细胞浸润。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号